Global Fusion Biopsy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Fusion Biopsy Market is presumed to reach the market size of nearly USD 1446.81 Million by 2032 from USD 652.56 Million in 2023 with a CAGR of 9.25% under the study period 2024-2032.

A Fusion Biopsy is used to obtain a detailed 3-D image of the prostate during a biopsy surgery. This method improves the visibility of an aberrant tissue area to lead the biopsy needle into it. After that, a sample of tissue can be taken and examined under a microscope for cancer indications. Other types of biopsies may miss prostate cancer cells, but a fusion biopsy may help locate them. It could aid in the early detection of cancer and treatment planning. MRI ultrasound fusion-guided biopsy is another name for this procedure. A sophisticated magnetic resonance imaging (MRI) scan is combined with an ultrasound image to enable urologists to pinpoint the prostate area that must be biopsied accurately. Doctors can use this method to sample the specific size of the prostate where cancer is suspected. The fusion biopsy can be divided into two categories based on the biopsy route: transperineal and transrectal. End-users of fusion biopsy include hospitals, diagnostic facilities, and ambulatory care clinics.

MARKET DYNAMICS

The high sensitivity and specificity of targeted MR/Ultrasound fusion biopsy in defining prostate lesions compared to other traditional procedures like TRUS biopsy, PSA test, or Digital Rectal Examination is expected to promote market expansion. The fusion biopsy system's reliability and reproducibility in diagnosing aggressive cancers are projected to make it a standard tool in prostate biopsy. The use of targeted MR/Ultrasound fusion biopsy devices has expanded due to an increasing number of radiologists obtaining experience in reading prostate MRI and the deployment of standard image grading methods such as PI-RADS and Gleason score. The increasing focus of government organizations in various countries on improving healthcare infrastructure will be a lucrative growth driver for the fusion biopsy market. Additionally, increased investment in the fusion biopsy sector will provide significant growth potential. The fusion biopsy market will likely see promising growth due to increased awareness about regular clinical examinations and acceptable reimbursement policies in various regions worldwide.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Fusion Biopsy. The growth and trends of Fusion Biopsy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Fusion Biopsy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Route

Transrectal
Transperineal

By End-use

Hospitals
Diagnostic Centers
Ambulatory Care Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Fusion Biopsy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Fusion Biopsy market include Eigen Health, Koninklijke Philips N.V., Hitachi Ltd., MedCom, ESAOTE SpA, . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11216669

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. FUSION BIOPSY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Route
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY ROUTE

5.1. Overview By Route
5.2. Historical and Forecast Data Analysis By Route
5.3. Transrectal Historic and Forecast Sales By Regions
5.4. Transperineal Historic and Forecast Sales By Regions

6. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY END-USE

6.1. Overview By End-use
6.2. Historical and Forecast Data Analysis By End-use
6.3. Hospitals Historic and Forecast Sales By Regions
6.4. Diagnostic Centers Historic and Forecast Sales By Regions
6.5. Ambulatory Care Centers Historic and Forecast Sales By Regions

7. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE FUSION BIOPSY COMPANIES

8.1. Fusion Biopsy Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF FUSION BIOPSY INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Eigen Health
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Koninklijke Philips N.V.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Hitachi Ltd.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. MedCom
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. ESAOTE SpA
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies